Silverback Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- September 19, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $47,500,000
Company Info
- Founding Year
- 2016
- Company Description
- Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways.
- Market
- Therapeutics
- Location
- Seattle, WA, USA
- Coinvestors
- OrbiMed, Celgene Corporation, Alexandria Venture Investments